Randomized Evaluation and Verification of Ventricular Enhancement
Status:
Enrolling by invitation
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
A prospective, multi-center, dual-arm randomized controlled study comparing treatment of
ischemic cardiomyopathy induced heart failure with the Revivent TC System plus Guideline
Directed Medical Therapy (GDMT) compared to GDMT alone.
Phase:
N/A
Details
Lead Sponsor:
BioVentrix
Collaborator:
Imaging Clinical Trial Services GmbH, Meditrial Europe Ltd.